← Leaderboards
Michael A Murphey-Corb
University Of Pittsburgh At Pittsburgh
$8,074,305
Attributed
$8,074,305
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$12,521,452 · 10
By mechanism
P01$7,460,914 · 5
R01$4,690,000 · 2
R21$263,177 · 1
U54$107,361 · 1
P41$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Ronald C Montelaro$16,007,779
- Joseph T Newsome$4,616,639
- Cristian Apetrei$24,938,676
- Robert Sterling Turner$10,888,966
- Charles R Rinaldo$100,535,685
Others in their field
Top investigators on “Simian Immunodeficiency Virus”
- Dennis R. Burton · Scripps Research Institute$71,748,023
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,231,383
- Rama Rao Amara · Emory University$51,549,482
- Ruth Margrit Ruprecht · Dana-Farber Cancer Institute$42,909,253
- Michael R. Farzan · Boston Children'S Hospital$42,371,664
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$36,786,312
Research focus
Simian Immunodeficiency VirusVaccine DevelopmentAids VaccinesVector VaccineVirus ReplicationImmunomodulatorsMucosal ImmunityViral VaccinesMacaca MulattaCytokineChemokineMacacaT-LymphocyteVaccinesAnimalsPeptidesBinding (Molecular Function)InfectionMucous MembraneHelper T LymphocyteActive ImmunizationImmune ResponseEnzyme Linked Immunosorbent AssayGut Associated Lymphoid Tissue
Grant awards (24)
Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa$678,745
R01 · FY2013 · AI · contact PI
Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa$728,861
R01 · FY2012 · AI · contact PI
Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa$745,851
R01 · FY2011 · AI · contact PI
Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa$767,952
R01 · FY2010 · AI · contact PI
Defense Against Biowarfare and Emerging Infection Agents - Non Human Primate Core$107,361
U54 · FY2008 · AI · contact PI
An Adjuvanted Therapeutic DNA Vaccine for AIDS$776,346
P01 · FY2006 · AI · contact PI
Adjuvanted Epitope Vaccine to Target HIV Reservoirs$549,072
R01 · FY2006 · AI · contact PI
An Adjuvanted Therapeutic DNA Vaccine for AIDS$939,736
P01 · FY2005 · AI
Adjuvanted Epitope Vaccine to Target HIV Reservoirs$596,881
R01 · FY2005 · AI
An Adjuvanted Therapeutic DNA Vaccine for AIDS$731,893
P01 · FY2004 · AI
Adjuvanted Epitope Vaccine to Target HIV Reservoirs$622,638
R01 · FY2004 · AI
A Novel Scrambled Antigen DNA Vaccine (SAVINE) Strategy$263,177
R21 · FY2003 · AI
DEVELOPMENT OF AN AIDS PROTOTYPE VACCINE USING SIV$1,478,693
P01 · FY2002 · AI
SIV GENOTYPIC VARIATION &MUCOSAL IMMUNITY, TISSUE TROPISM &DISEASE PROGRESSION$0
P41 · FY2002 · RR
SIV GENOTYPIC VARIATION &MUCOSAL IMMUNITY, TISSUE TROPISM &DISEASE PROGRESSION$0
P41 · FY2002 · RR
DEVELOPMENT OF AN OPTIMAL LIVE ATTENUATED SIV VACCINE$0
P01 · FY2002 · AI
DEVELOPMENT OF AN AIDS PROTOTYPE VACCINE USING SIV$1,552,287
P01 · FY2001 · AI
SIV GENOTYPIC VARIATION &MUCOSAL IMMUNITY, TISSUE TROPISM &DISEASE PROGRESSION$0
P41 · FY2001 · RR
ROLE OF THE GUT IN IMMUNOTHRAPY$0
P01 · FY2001 · AI
CORE--SIMIAN$0
P01 · FY2001 · AI
DEVELOPMENT OF AN OPTIMAL LIVE ATTENUATED SIV VACCINE$0
P01 · FY2001 · AI
DEVELOPMENT OF AN AIDS PROTOTYPE VACCINE USING SIV$1,416,167
P01 · FY2000 · AI
DEVELOPMENT OF AN OPTIMAL LIVE ATTENUATED SIV VACCINE$351,855
P01 · FY2000 · AI
CORE--SIMIAN$213,937
P01 · FY2000 · AI